Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Abbott (ABT) Tops Q3 EPS by 20c, Beats on Revenue, Raises FY22 Guidance
October 19, 2022 7:31 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $1.15, $0.20 better than the analyst estimate of $0.95. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $9.63 billion.
GUIDANCE:
Abbott sees FY2022 EPS of $5.17-$5.23, versus the consensus of $5.05.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More